Hoffmann O, Masuhr F
Klinik für Neurologie, Alexianer St. Josefs-Krankenhaus Potsdam-Sanssouci, Allee nach Sanssouci 7, 14471, Potsdam, Deutschland.
Abteilung Neurologie, Bundeswehrkrankenhaus Berlin, Berlin, Deutschland.
Nervenarzt. 2016 Feb;87(2):169-77. doi: 10.1007/s00115-015-0044-2.
According to the German Medical Council guidelines, the proof of irreversible brain death can be carried out using clinical investigations alone or can necessitate the use of ancillary tests (ATs), depending on the patient age and type of brain injury.
Retrospective evaluation of the diagnostics of irreversible brain death, which were carried out using ATs according to the third edition of the guidelines between January 2001 and December 2010 in Berlin, Brandenburg and Mecklenburg-Western Pomerania and were registered at the German National Foundation for Organ Transplantation.
In 1401 patients (aged 0-94 years) a total of 1636 ATs were carried out. The most frequently used additional procedure for the first AT was an electroencephalogram (EEG) in 71.7 %. Confirmatory results regarding irreversibility were reported for 93.6 % of the initial ATs. Negative results of ATs were less common with primary supratentorial brain lesions (2.9 %) compared to infratentorial lesions (13.7 %), secondary hypoxic brain damage (8.1 %) and children younger than 2 years old (18.5 %). Regardless of the AT results, a return of clinical brain function was never documented. The timing, type and repetition of ATs were variable. In most cases the diagnostic process was clearly accelerated by the use of ATs but was significantly delayed in 10.1 % compared to a purely clinical proof of irreversible brain death.
ATs by themselves do not provide evidence of the cessation of all brain functions. Instead, they are used to prove the irreversibility of the clinically defined syndrome. For patients over 2 years old and in the absence of primary brainstem lesions, clinical re-assessment and ATs are considered to be equally accurate in demonstrating irreversibility. A standardization of diagnostic procedures between hospitals would be desirable.
根据德国医学委员会的指南,不可逆性脑死亡的判定可以仅通过临床检查进行,也可能需要使用辅助检查(ATs),这取决于患者的年龄和脑损伤类型。
对2001年1月至2010年12月期间在柏林、勃兰登堡和梅克伦堡 - 前波美拉尼亚按照指南第三版使用ATs进行的不可逆性脑死亡诊断进行回顾性评估,这些诊断已在德国国家器官移植基金会登记。
在1401例患者(年龄0 - 94岁)中,共进行了1636次ATs。首次AT最常用的附加检查是脑电图(EEG),占71.7%。93.6%的首次AT报告了关于不可逆性的确认结果。与幕下病变(13.7%)、继发性缺氧性脑损伤(8.1%)和2岁以下儿童(18.5%)相比,幕上原发性脑病变患者ATs结果为阴性的情况较少(2.9%)。无论ATs结果如何,从未记录到临床脑功能恢复。ATs的时间、类型和重复情况各不相同。在大多数情况下,使用ATs明显加快了诊断过程,但与单纯临床判定不可逆性脑死亡相比,有10.1%的情况诊断过程明显延迟。
ATs本身并不能提供所有脑功能停止的证据。相反,它们用于证明临床定义综合征的不可逆性。对于2岁以上且无原发性脑干病变的患者,临床重新评估和ATs在证明不可逆性方面被认为同样准确。医院之间诊断程序的标准化是可取的。